Uric acid, phosphate and oxalate stones: Treatment and prophylaxis

Urologia Internationalis

Volumn 72, Issue SUPPL. 1, 2004, Pages 24-28

  Caramia, G ^a,b   Di Gregorio, L ^a   Tarantino, M L ^a   Galuffo, A ^a   Iacolino, R ^a   Caramia, M ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

Medical therapy; Prophylaxis; Renal stones

Indexed keywords

ACETAZOLAMIDE; ACETOHYDROXAMIC ACID; ALLOPURINOL; AMMONIUM CHLORIDE; BICARBONATE; CALCIUM CHELATING AGENT; CALCIUM PHOSPHATE; CITRATE POTASSIUM; EDETIC ACID; MAGNESIUM CITRATE; METHIONINE; PHOSPHATE; STRUVITE; THIAZIDE DIURETIC AGENT; URIC ACID;

ABDOMINAL PRESSURE; ALKALINIZATION; ALKALOSIS; BACTERIUM; CALCIUM STONE; CLINICAL TRIAL; CONFERENCE PAPER; DIARRHEA; DIURESIS; DYSPEPSIA; GASTROINTESTINAL SYMPTOM; HEARTBURN; HUMAN; HYPERCALCIURIA; HYPEROXALURIA; HYPERURICEMIA; HYPOCITRATURIA; HYPOKALEMIA; LIFESTYLE; NEPHROLITHIASIS; POTASSIUM DEPLETION; PRIORITY JOURNAL; RELAPSE; SIDE EFFECT; SODIUM RETENTION; STONE DISSOLUTION; ULTRASONIC LITHOTRIPSY; URIC ACID STONE; URIC ACID URINE LEVEL; URINE ACIDIFICATION;

CALCIUM OXALATE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; KIDNEY CALCULI; LITHOTRIPSY; MALE; PROGNOSIS; RISK ASSESSMENT; URIC ACID;

EID: 2342596289     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000076587     Document Type: Conference Paper

References (16)

1. Ettinger B, Pak CYC, et al: Potassium magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. J Urol 1997;158:2063-2069.
2. Wang YH, et al: Citrate and urease-induced crystallization in vitro. Urol Res 1993;21:109-112.
3. Grases F, et al: Uric acid urolithiasis and crystallization inhibitors. Urol Int 1999;62:201.
4. Osther PL, et al: Metabolic evaluation and medical management of upper urinary tract stone disease. Guideline from Scandinavian Cooperative Group for Urinary Stones. Scand J Urol Nephrol 1999;33:372-381.
5. Wall I, Tiselius HG: Longterm acidification of urine in patients treated for infected renal stones. Urol Int 1990;45:336-341.
6. Tiselius HG, et al: Minimally invasive treatment of infection staghorn stones with shock waves lithotripsy and chemolysis. Scand J Urol Nephrol 1999;33:286-290.
7. Menon M, et al: Litiasi urinaria: eziologia, diagnosi e terapia medica. In Urologia di Campbell, VII Ed. Ital; cap 91, pp 2695-2767.
8. Griffith DP, et al: Experimental and clinical trials of lithostat (acetohydroxamic acid AHA); in Martelli A, et al. (ed): Inhibitors of Crystallization in Renal Lithiasis and Their Clinical Application. Bologna, Acta Medica, 1998, pp 228-235.
9. Griffith DP, et al: Prevention of infected urinary stones by urease inhibition. Invest Urol 1973;11:228-233.
10. Griffith DP, et al: Infection (urease) stones. Miner Elettrol Metab 1987;13:278-285.
11. Mulvaney WP, Hennings DC: Solvent treatment of urinary calculi: Refinements in technique. J Urol 1962;88:145.
12. Nemoy NJ, Stamey TA: Surgical, bacteriological and biochemical management of infection stones. JAMA 1971;215:1470-1476.
13. Jacobs SC, Gittes RF: Dissolution of residual renal calculi with Hemiacidrin. J Urol 1976;115:2-4.
14. Marangella M, et al: Idiopathic calcium nephrolithiasis. Nephron 1999;81(suppl 1):38-44.
15. Tiselius HG: Possibilities for preventing recurrent calcium stone formation: Principles for metabolic evaluation for patients with calcium stone disease. BJU Int 2001;88:158-168.
16. Cicerello E, et al: Citrato alcalino e calcolosi urinaria. Urol Pratica 2002;3:75-80.